Medicure Stock Net Income
| MPH Stock | CAD 1.12 0.02 1.75% |
As of the 17th of February 2026, Medicure secures the Downside Deviation of 8.94, mean deviation of 3.56, and Risk Adjusted Performance of 0.0135. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medicure, as well as the relationship between them. Please verify Medicure downside variance, kurtosis, as well as the relationship between the treynor ratio and standard deviation to decide if Medicure is priced some-what accurately, providing market reflects its recent price of 1.12 per share.
Medicure Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.327 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -1.2 M | -1.3 M | |
| Net Loss | -935.1 K | -888.3 K | |
| Net Loss | -654.3 K | -621.6 K | |
| Net Loss | (0.09) | (0.09) | |
| Net Income Per E B T | 1.19 | 1.78 |
Medicure | Net Income |
The evolution of Net Income for Medicure provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Medicure compares to historical norms and industry peers.
Latest Medicure's Net Income Growth Pattern
Below is the plot of the Net Income of Medicure over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Medicure financial statement analysis. It represents the amount of money remaining after all of Medicure operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Medicure's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medicure's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1.04 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Medicure Net Income Regression Statistics
| Arithmetic Mean | 3,779,946 | |
| Geometric Mean | 3,382,301 | |
| Coefficient Of Variation | 388.03 | |
| Mean Deviation | 9,796,469 | |
| Median | (922,000) | |
| Standard Deviation | 14,667,406 | |
| Sample Variance | 215.1T | |
| Range | 63.2M | |
| R-Value | (0.24) | |
| Mean Square Error | 216.1T | |
| R-Squared | 0.06 | |
| Significance | 0.35 | |
| Slope | (699,963) | |
| Total Sum of Squares | 3442.1T |
Medicure Net Income History
Medicure Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Medicure is extremely important. It helps to project a fair market value of Medicure Stock properly, considering its historical fundamentals such as Net Income. Since Medicure's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medicure's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medicure's interrelated accounts and indicators.
Click cells to compare fundamentals
Medicure 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medicure's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medicure.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Medicure on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Medicure or generate 0.0% return on investment in Medicure over 90 days. Medicure is related to or competes with DRI Healthcare, HLS Therapeutics, Cipher Pharmaceuticals, OrganiGram Holdings, Aquestive Therapeutics, Dexterra, and European Residential. Medicure Inc., a pharmaceutical company, engages in the development and commercialization of therapies for the cardiovas... More
Medicure Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medicure's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medicure upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.94 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 52.07 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 12.61 |
Medicure Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medicure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medicure's standard deviation. In reality, there are many statistical measures that can use Medicure historical prices to predict the future Medicure's volatility.| Risk Adjusted Performance | 0.0135 | |||
| Jensen Alpha | 0.095 | |||
| Total Risk Alpha | (0.52) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.03) |
Medicure February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0135 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 3.56 | |||
| Semi Deviation | 4.86 | |||
| Downside Deviation | 8.94 | |||
| Coefficient Of Variation | 17454.38 | |||
| Standard Deviation | 7.43 | |||
| Variance | 55.16 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | 0.095 | |||
| Total Risk Alpha | (0.52) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 52.07 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 12.61 | |||
| Downside Variance | 79.93 | |||
| Semi Variance | 23.64 | |||
| Expected Short fall | (10.72) | |||
| Skewness | 1.65 | |||
| Kurtosis | 8.53 |
Medicure Backtested Returns
Medicure has Sharpe Ratio of -0.0405, which conveys that the firm had a -0.0405 % return per unit of risk over the last 3 months. Medicure exposes twenty-six different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medicure's Risk Adjusted Performance of 0.0135, downside deviation of 8.94, and Mean Deviation of 3.56 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -1.04, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Medicure are expected to decrease slowly. On the other hand, during market turmoil, Medicure is expected to outperform it slightly. At this point, Medicure has a negative expected return of -0.24%. Please make sure to verify Medicure's information ratio, downside variance, price action indicator, as well as the relationship between the treynor ratio and kurtosis , to decide if Medicure performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.05 |
Virtually no predictability
Medicure has virtually no predictability. Overlapping area represents the amount of predictability between Medicure time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medicure price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Medicure price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Medicure Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Medicure reported net income of (1.04 Million). This is 100.3% lower than that of the Pharmaceuticals sector and 101.48% lower than that of the Health Care industry. The net income for all Canada stocks is 100.18% higher than that of the company.
Medicure Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicure's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medicure could also be used in its relative valuation, which is a method of valuing Medicure by comparing valuation metrics of similar companies.Medicure is currently under evaluation in net income category among its peers.
Medicure Current Valuation Drivers
We derive many important indicators used in calculating different scores of Medicure from analyzing Medicure's financial statements. These drivers represent accounts that assess Medicure's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Medicure's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 9.4M | 10.4M | 14.6M | 9.2M | 8.3M | 7.9M | |
| Enterprise Value | 6.9M | 6.3M | 8.8M | 2.9M | 2.6M | 2.5M |
Medicure Fundamentals
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0647 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 8.57 M | ||||
| Shares Outstanding | 10.44 M | ||||
| Shares Owned By Insiders | 26.86 % | ||||
| Shares Owned By Institutions | 23.09 % | ||||
| Number Of Shares Shorted | 2.53 K | ||||
| Price To Earning | 22.88 X | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 0.45 X | ||||
| Revenue | 21.91 M | ||||
| Gross Profit | 12.77 M | ||||
| EBITDA | (1.17 M) | ||||
| Net Income | (1.04 M) | ||||
| Cash And Equivalents | 45.7 M | ||||
| Cash Per Share | 3.07 X | ||||
| Total Debt | 8.9 M | ||||
| Debt To Equity | 0.70 % | ||||
| Current Ratio | 4.71 X | ||||
| Book Value Per Share | 1.66 X | ||||
| Cash Flow From Operations | 1.38 M | ||||
| Short Ratio | 1.35 X | ||||
| Earnings Per Share | (0.33) X | ||||
| Target Price | 2.8 | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 11.69 M | ||||
| Total Asset | 29.68 M | ||||
| Retained Earnings | (66.89 M) | ||||
| Working Capital | 7.5 M | ||||
| Net Asset | 29.68 M |
About Medicure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicure Stock Analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.